Fibromyalgia in patients with rheumatoid arthritis. A 10-year follow-up study, results from the Oslo Rheumatoid Arthritis Register.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
Historique:
received: 15 07 2018
accepted: 05 11 2018
pubmed: 9 1 2019
medline: 14 5 2019
entrez: 9 1 2019
Statut: ppublish

Résumé

To examine cross-sectional and longitudinal relationships between fibromyalgia (FM) and rheumatoid arthritis (RA) disease activity. 636 patients in the observational Oslo RA register (ORAR) were invited to a clinical examination in 1999. 28-tender and swollen joint counts (TJC, SJC) and 18-tender points were assessed, the RA disease activity score (DAS-28) calculated. Fibromyalgia (FM) was diagnosed according to 1990 (FM-1990) and modified 2011 (mFM-2011) ACR criteria. At the 10-year follow-up patients completed the RA Disease Activity Index (RADAI) and Routine Assessment of Patient Index Data 3 (RAPID-3). Baseline and 10-year RA disease activity were compared across presence/absence of FM. Linear regression models were constructed with 10-year RADAI and RAPID-3 as outcome. 502 patients participated at baseline data-collection and 10-year data was available in 236. At baseline, mean (SD) age was 59.5 (12.5) years and 87% were female. 9% and 30% had FM-1990 and mFM-2011 respectively. RA-FM patients were predominantly female with higher SJC, TJC, and DAS-28 at baseline. Baseline RA-FM predicted higher levels of RADAI and RAPID-3 at the 10-year follow-up. RA-FM was associated with significantly higher levels of cross-sectional and longitudinal RA disease activity. FM should be considered in patients with RA not reaching remission.

Identifiants

pubmed: 30620293
pii: 13149

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

58-62

Auteurs

Sella Aarrestad Provan (SA)

Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway. sellaprovan@gmail.com.

Cathrine Austad (C)

Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.

Vera Halsaa (V)

Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.

Hilde Berner Hammer (HB)

Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.

Tore Kristian Kvien (TK)

Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.

Tillmann Uhlig (T)

Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH